Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04730921Not ApplicableCompleted

Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block (LEAP-Block)

Role: collaborator

NCT04624854Phase 4Completed

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Role: collaborator

NCT05105321Phase 4Not Yet Recruiting

Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)

Role: collaborator

NCT02306616Completed

CCC Project- Acute Coronary Syndrome

Role: collaborator

NCT02309398Completed

CCC Project - Atrial Fibrillation

Role: collaborator

NCT01732952Unknown

Dyslipidemia International Survey-China

Role: lead

All 6 trials loaded